Page fusion proteins

Details for Australian Patent Application No. 2008265983 (hide)

Owner Galactica Pharmaceuticals

Inventors Hilbert, David M.; Bleck, Gregory T.

Agent Davies Collison Cave

Pub. Number AU-A-2008265983

PCT Pub. Number WO2008/157378

Priority 60/943,994 14.06.07 US

Filing date 13 June 2008

Wipo publication date 24 December 2008

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/157378 Priority application(s): WO2008/157378

11 February 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Rage fusion proteins

25 February 2010 Corrigenda

  Amendments - Amendments Made Under the name Galactica Pharmaceuticals, Inc., Application No. 2008265983, under INID(54), correct the invention title to RAGE fusion proteins

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008265984-Covalent diabodies and uses thereof

2008265974-Use of TACI-Ig fusion protein such as atacicept for the manufacture of a medicament for treating lupus erythematosus